undamentalytics Newsletter

ICU Medical Inc insider trading

Every open-market purchase and sale by ICU Medical Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No insider has bought shares on the open market in five years.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
ICU Medical Inc insider open-market trades
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following ICU Medical Inc’s insiders pay?

From January 11, 2010 to August 13, 2026, 23 insiders reported 5 open-market purchases and 201 sales not made under a pre-set plan in ICU Medical Inc. Twelve months after each purchase was reported, the shares were +23.7% against the S&P 500 on average (median +30.0%), over 5 purchases with a full year of prices; 80% beat the index. After sales, the shares moved +7.3% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on March 6, 2014 into $36,773 by November 2, 2026, +10.9% a year. It held shares 29% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $18,619 (+5.0% a year), and held throughout $49,742 (+13.5%).

$0$20.0k$40.0k 2014201620182020202220242026 $49.7k$36.8k$18.6k
Copying ICU Medical Inc's insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by ICU Medical Inc's insiders from March 6, 2014, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 29% of the time.
ICU Medical Inc: each insider's record
InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Lopez George A Chairman 2 +20.2% (2) 50% 57 +2.6% (57) March 14, 2024
Costello Richard A Vice President Sales 0 — — 19 +6.3% (19) February 26, 2014
Swinney Robert S Director 0 — — 18 +28.8% (18) September 15, 2021
Burcar Alison D Vice President and Gen'l Mgr. 0 — — 13 +10.7% (13) June 21, 2018
Sanzone Virginia Ruth VP, General Counsel 0 — — 12 +1.7% (10) May 15, 2026
Voigtlander Christian B. Chief Operating Officer 0 — — 12 −16.6% (11) August 11, 2026
Saucedo Joseph R Director 0 — — 8 +18.1% (8) May 14, 2018
Woolson Daniel VP, GM-Infusion Capital 0 — — 8 −2.6% (5) August 13, 2026
Connors John J Director 0 — — 7 +15.0% (7) February 13, 2015
Jain Vivek Chairman and CEO 2 +30.7% (2) 100% 5 +29.4% (5) August 14, 2025
Finney Elisha W Director 0 — — 6 −16.2% (4) August 11, 2026
Riggs Steven VP Operations 0 — — 6 +26.8% (6) December 12, 2014
Lamb Scott E Chief Financial Officer, 0 — — 5 +30.9% (5) December 10, 2019
Greenberg David C. Director 1 +16.6% (1) 100% 3 −33.5% (2) May 13, 2026
Kovalchik Michael T Director 0 — — 4 −0.5% (4) November 5, 2013
Sherman Richard Md Director 0 — — 4 +22.4% (4) March 14, 2017
Brown Jack Director 0 — — 3 +31.6% (3) February 18, 2015
Mccall Thomas D Vice President and Gen'l Mgr. 0 — — 3 −3.4% (3) August 27, 2018
Sousa Ben Chief Information Officer 0 — — 3 −11.3% (2) August 12, 2026
Mcgrody Kevin J Controller 0 — — 2 −3.9% (2) June 11, 2019
C.P. Pharmaceuticals International C.V. Director 0 — — 1 −39.8% (1) November 16, 2018
Pfizer Production LLC Director 0 — — 1 −48.3% (1) August 15, 2018
Smiths Group PLC and related entities Other 0 — — 1 +19.7% (1) March 1, 2024

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded ICU Medical Inc

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of ICU Medical Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 1 buying crowd with six months of prices, it averaged +5.7% against the index. After 17 selling crowds, +1.8%. One company's history is too short to judge by; the test across every company is the better guide.

MonthCrowd3 months on, vs S&P 5006 months12 months
May 29, 20263 selling+27.4%not yetnot yet
November 28, 20253 selling−3.7%−23.9%not yet
August 29, 20252 buying+10.0%+5.7%+14.4%
May 30, 20254 selling−15.1%−6.5%−33.6%
December 31, 20243 selling−0.6%−22.9%−25.8%
March 28, 20245 selling+6.3%+52.6%+19.8%
September 30, 20213 selling−8.8%−10.5%−20.0%
August 31, 20203 selling−9.8%−8.8%−31.6%
May 31, 20183 selling−2.9%−18.5%−29.6%
November 30, 20174 selling+12.4%+32.9%+6.8%
March 31, 20175 selling+9.9%+14.1%+48.7%
August 31, 20163 selling+18.5%+9.5%+23.6%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Latest 12 of 19. Total returns from the month end; past patterns are not a forecast.

← Back to ICU Medical Inc · Funds · Politicians